| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10172115 | Respiratory Investigation | 2014 | 8 Pages |
Abstract
We concluded that IPF patients with a mild disease, diagnosis by SLB, or both showed indications of a good response to pirfenidone. In addition, acid-secretion inhibitors may reduce the frequency of anorexia, nausea, or both from pirfenidone.
Keywords
IPFERSMRCTLCSurfactant protein-DATSKL-6JRSSLBH2RAsDLCOUIPPPIsPaO2HRCTJapanese Respiratory SocietyEuropean Respiratory SocietyAmerican Thoracic SocietySurgical lung biopsyAnorexiaarterial oxygen tensionhigh-resolution computed tomographyKrebs von den Lungen-6Medical Research Councildiffusing capacity of carbon monoxideVital capacityTotal lung capacityidiopathic pulmonary fibrosisProton pump inhibitorsUsual interstitial pneumoniaPirfenidone
Related Topics
Life Sciences
Immunology and Microbiology
Immunology and Microbiology (General)
Authors
Toru Arai, Yoshikazu Inoue, Yumiko Sasaki, Kazunobu Tachibana, Keiko Nakao, Chikatoshi Sugimoto, Tomohisa Okuma, Masanori Akira, Masanori Kitaichi, Seiji Hayashi,